Mary Lou Carrion-Petersen

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

Valery T. Miller, John C. LaRosa, Vanessa M. Barnabei et al. · JAMA · 1995 · 605 citations

Medicine, Endocrinology, Pharmacology +15

Overview of recruitment for the osteoporotic fractures in men study (MrOS)

Janet Babich Blank, Peggy M. Cawthon, Mary Lou Carrion-Petersen et al. · Contemporary Clinical Trials · 2005 · 581 citations

Medicine, Orthopedic Surgery, Bone Metabolism +11

Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

David M. Nathan, William C. Knowler, Sharon L. Edelstein et al. · Diabetes Care · 2019 · 124 citations · Full text

Medicine, Endocrinology, Preventive Medicine +14

Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS)

Leigh Perreault, Qing Pan, Emily B. Schroeder et al. · Diabetes Care · 2019 · 104 citations · Full text

Medicine, Chronic Disease Prevention, Preventive Medicine +17

Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

Christine G. Lee, Brandy M. Heckman‐Stoddard, Dana Dabelea et al. · Diabetes Care · 2021 · 99 citations · Full text

Medicine, Pharmacotherapy, Preventive Medicine +17